Reply to comments: duration of antimicrobial therapy for Gram-negative bacteremia secondary to urinary source of infection

被引：0
|
作者：
Majdi N. Al-Hasan
Avery N. Nelson
Julie Ann Justo
Helmut Albrecht
Joseph Kohn
P. Brandon Bookstaver
机构：
[1] University of South Carolina School of Medicine,Department of Medicine
[2] Palmetto Health USC Medical Group,Department of Clinical Pharmacy and Outcomes Sciences
[3] University of South Carolina College of Pharmacy,Department of Pharmacy
[4] Palmetto Health Richland,undefined
来源：
Infection | 2018年 / 46卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：283 / 284
页数：1
相关论文
共 50 条
  • [31] What is the evidence for the duration of antibiotic therapy in Gram-negative bacteraemia caused by urinary tract infection? A systematic review of the literature
    Coats, Josh
    Rae, Nikolas
    Nathwani, Dilip
    JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2013, 1 (01) : 39 - 42
  • [32] AMIKACIN THERAPY FOR SERIOUS GRAM-NEGATIVE INFECTION
    POLLOCK, AA
    BERGER, SA
    RICHMOND, AS
    SIMBERKOFF, MS
    RAHAL, JJ
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1977, 237 (06): : 562 - 564
  • [33] Gram-negative superbugs: inappropriate antimicrobial therapy and mortality
    Blondeau, J. M.
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2013, 6 (04) : 347 - 349
  • [34] Impact of antimicrobial stewardship and rapid microarray testing on patients with Gram-negative bacteremia
    Rivard, K. R.
    Athans, V.
    Lam, S. W.
    Gordon, S. M.
    Procop, G. W.
    Richter, S. S.
    Neuner, E.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2017, 36 (10) : 1879 - 1887
  • [35] Impact of antimicrobial stewardship and rapid microarray testing on patients with Gram-negative bacteremia
    K. R. Rivard
    V. Athans
    S. W. Lam
    S. M. Gordon
    G. W. Procop
    S. S. Richter
    E. Neuner
    European Journal of Clinical Microbiology & Infectious Diseases, 2017, 36 : 1879 - 1887
  • [36] Combination of a Rapid Diagnostic Assay and Antimicrobial Stewardship Intervention for Gram-Negative Bacteremia
    Ventres, Julian J.
    Ting, Michelle H.
    Parente, Diane M.
    Rogers, Ralph
    Norris, Ashlyn M.
    Benitez, Gregorio
    Shehadeh, Fadi
    Bobenchik, April M.
    Mylonakis, Eleftherios
    Chapin, Kimberle C.
    Cunha, Cheston B.
    OPEN FORUM INFECTIOUS DISEASES, 2024, 11 (09):
  • [37] Nosocomial Gram-negative bacteremia in intensive care: epidemiology, antimicrobial susceptibilities, and outcomes
    Sligl, Wendy Irene
    Dragan, Tatiana
    Smith, Stephanie Wrenn
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2015, 37 : 129 - 134
  • [38] ANTIMICROBIAL SUSCEPTIBILITY IN GRAM-NEGATIVE BACTEREMIA - ARE NOSOCOMIAL ISOLATES REALLY MORE RESISTANT
    MCGOWAN, JE
    HALL, EC
    PARROTT, PL
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (11) : 1855 - 1859
  • [39] Evaluating antimicrobial duration for Gram-negative bacteremia in patients with neutropenia due to hematologic malignancy or hematopoietic stem cell transplantation
    Ranganath, Nischal
    Yetmar, Zachary A.
    McCandless, Audrey R.
    Rivera, Christina G.
    Lahr, Brian D.
    Tande, Aaron J.
    Shah, Aditya S.
    TRANSPLANT INFECTIOUS DISEASE, 2023, 25 (05)
  • [40] DRUG-THERAPY FOR GRAM-NEGATIVE BACTEREMIA IN CANCER-PATIENTS
    BRYAN, CS
    PENDLETON, AL
    INFECTIONS IN SURGERY, 1990, 9 (10): : 31 - 38
12345